video thumbnail

Asthma Management

{{isShortDescriptionLonger && !showFullDescription ? shortDescription.slice(0, 250) : shortDescription}}... See {{showFullDescription? 'less' : 'more'}}

Write A New Comment

0 Comments

In this lecture Dr. Mobeen discusses the severeity assessment of asthma, management approach according to the severeity, and drugs with their dose adjustment in a 6 step approach.

Initial visit workup:

  • Diagnosis (separate lecture)
  • Severity assessment
  • Medication.
    • Inhaled Corticosteroids (ICS)
    • Short acting beta agonists (SABA)
    • Long acting beta agonists (LABA)
    • Leukotrine Receptor Antagonists (LTRA)
    • Cromolyn
    • Theophyline
    • Oral Corticosteroids
  • Plan of treatment.
  • Follow up

Follow up visit:

  • Assess control
  • Review medication compliance
  • Review side-effects
  • Decide medication modification if needed.
  • Update the plan if necessary.
  • Plan follow up.

In this video we will learn about:

1. Step wise approach to asthma management. 

2. Severity assessment. 

3. SABA and mechanism of action.

4. Oral and inhaled corticosteroids.

5. Leukotriene receptor antagonist.

6. Plan of treatment.

7. Assessment of compliance and improvement.

8. Side effects of treatment. 

Following answers are created by ChatGPT. Occasionally the answer may be harmful, incorrect, false, misleading, incomplete, or limited in knowledge of world. Please contact your doctor for all healthcare decisions. Also, double check the answer provided by the AI below.

Please login to access this content.

Don't have an account?

Start Your Free trial

No credit card information needed.

Recent Videos
Related Videos

Copyright © 2015-2023
All Rights Reserved by DrBeen

All information contained in and produced by DrBeen corp is provided for educational purposes only. This information should not be used for the diagnosis or treatment of any health problem or disease.
THIS INFORMATION IS NOT INTENDED TO REPLACE CLINICAL JUDGMENT OR GUIDE INDIVIDUAL PATIENT CARE IN ANY MANNER.
Click here for full notice and disclaimer.